Ann: Optiscan to present at Head & Neck Cancer World Congress, page-6

I doubt there was anyone here who attended the presentation and due to the restriction I assume on sharing of the conference material, we won't know how it was received.

However, I am not sure I agree with your conclusion on his statement about commercialisation, that the device won't be ready till 2nd half 2023. He simply said 2023 and we could just as easily as assume it could be 1st half.

We know there has already been alot of planning on the marketing and distribution channels, so once FDA comes through, there shouldn't be a long lead in to getting the product into the marketplace. It's more about, obviously first the FDA approval, and then the demand. If that FDA comes through before end of calendar 2022 though, no reason we get launch early 2023.